Related references
Note: Only part of the references are listed.Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells
Bozhena O. Vynnytska et al.
ANTI-CANCER DRUGS (2011)
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
T-S Yang et al.
BRITISH JOURNAL OF CANCER (2010)
Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes
Yaroslav P. Bobak et al.
CELL BIOLOGY INTERNATIONAL (2010)
Multicellular tumor spheroids: An underestimated tool is catching up again
Franziska Hirschhaeuser et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
Evan S. Glazer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116
Claudia Dittfeld et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
Linda J. Nicholson et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Assessment of Apoptosis by Immunohistochemistry to Active Caspase-3, Active Caspase-7, or Cleaved PARP in Monolayer Cells and Spheroid and Subcutaneous Xenografts of Human Carcinoma
Aude Bressenot et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1 alpha/Sp4
Wen-Bin Tsai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich et al.
NATURE PROTOCOLS (2009)
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
Tawnya L. Bowles et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
HIF-1α in endurance training:: suppression of oxidative metabolism
Steven D. Mason et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Selective radio sensitization by nitric oxide in tumor cell lines
Lucia Policastro et al.
CANCER LETTERS (2007)
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase
Cheol-Yong Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion
Paul Ning-Man Cheng et al.
CANCER RESEARCH (2007)
Experimental anti-tumor therapy in 3-D: Spheroids - old hat or new challenge?
Juergen Friedrich et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
Peter W. Szlosarek et al.
CLINICAL CANCER RESEARCH (2006)
Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies
PA Ascierto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines
DN Wheatley et al.
CANCER LETTERS (2005)
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers - A method for identifying cancers sensitive to arginine deprivation
BJ Dillon et al.
CANCER (2004)
The use of 3-D cultures for high-throughput screening: The multicellular spheroid model
LA Kunz-Schughart et al.
JOURNAL OF BIOMOLECULAR SCREENING (2004)
Controlling cancer by restricting arginine availability - arginine-catabolizing enzymes as anticancer
DN Wheatley
ANTI-CANCER DRUGS (2004)
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies
F Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The mechanism of L-canavanine cytotoxicity: Arginyl tRNA synthetase as a novel target for anticancer drug discovery
AK Bence et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2003)
L-Canavanine as a radiosensitization agent for human pancreatic cancer cells
AK Bence et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Role of nitric oxide in the regulation of HIF-1α expression during hypoxia
FH Agani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells
L Scott et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
